Shopping Cart 0
Cart Subtotal
USD 0

Sarah Cannon Research Institute LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Sarah Cannon Research Institute LLC (SCRI) is a research institute that offers integrated cancer services. The institute conducts clinical research programs for advancing cancer therapies. Its services include blood cancer network, cancer care overview, cardiovascular research, contract research organization, nurse navigators, oncology research, personalized medicine, radiation oncology, and site management organization. It offers early oncology drug development in both solid tumors and hematologic malignancies. SCRI conducts research in the fields of oncology and cardiology. The institute partners with investigators and pharmaceutical and biotech companies to conduct clinical trials. It has operations in Austin, Dallas, Denver, Kansa City, London, Nashville, North Florida, Richmond, and San Antonio, the US. SCRI is headquarters in Nashville, Tennessee, the US.

Sarah Cannon Research Institute LLC-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 10

Foundation Medicine Enters into Agreement with Sarah Cannon Research Institute 11

Boehringer Ingelheim Expands Agreement with Sarah Cannon Research Institute 12

Eli Lilly Enters into Co-Development Agreement with Sarah Cannon Research Institute 13

Biocept Enters into Research Agreement with Sarah Cannon Research Institute 14

Sarah Cannon Research Institute And AstraZeneca Enter Into Agreement For Personalized Medicine 15

Acquisition 16

Sarah Cannon Research Institute Acquires Clinical Development 16

Sarah Cannon Research Institute LLC-Key Competitors 17

Sarah Cannon Research Institute LLC-Key Employees 18

Sarah Cannon Research Institute LLC-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Corporate Communications 21

Jan 11, 2018: Sarah Cannon Names Dr. Johanna C. Bendell Chief Development Officer 21

Product News 22

Jun 28, 2018: Sarah Cannon Research Institute-UK Offers TIL Therapy to Patients with Metastatic Melanoma 22

Appendix 23

Methodology 23

About GlobalData 23

Contact Us 23

Disclaimer 23


List Of Figure

List of Figures

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Key Facts 2

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Sarah Cannon Research Institute LLC, Deals By Therapy Area, 2012 to YTD 2018 8

Sarah Cannon Research Institute LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 10

Foundation Medicine Enters into Agreement with Sarah Cannon Research Institute 11

Boehringer Ingelheim Expands Agreement with Sarah Cannon Research Institute 12

Eli Lilly Enters into Co-Development Agreement with Sarah Cannon Research Institute 13

Biocept Enters into Research Agreement with Sarah Cannon Research Institute 14

Sarah Cannon Research Institute And AstraZeneca Enter Into Agreement For Personalized Medicine 15

Sarah Cannon Research Institute Acquires Clinical Development 16

Sarah Cannon Research Institute LLC, Key Competitors 17

Sarah Cannon Research Institute LLC, Key Employees 18

Sarah Cannon Research Institute LLC, Other Locations 20

Sarah Cannon Research Institute LLC, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Sarah Cannon Research Institute LLC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.